These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2870990)

  • 21. Effect of betaxolol on heart rate at rest and during exercise.
    Kesteloot H; Missotten A; Coupez-Lopinot R; Sluyts R
    Acta Cardiol; 1982; 37(2):117-27. PubMed ID: 6125074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetic and pharmacodynamic study of four different brands of propranolol in normal volunteers.
    Biswas NR; Garg SK; Kumar N; Mukherjee S; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):515-9. PubMed ID: 2583878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Betaxolol versus nifedipine in the treatment of essential hypertension].
    Steiner A; Hany S; Bättig B; Jenni R; Troesch M; Willimann P; Graf A; Leutenegger F; Angehrn V; Beck G
    Schweiz Rundsch Med Prax; 1988 Oct; 77(41):1101-3. PubMed ID: 2907178
    [No Abstract]   [Full Text] [Related]  

  • 24. [Evaluation of the duration of the effect of a single dose of nadolol on the product frequency x tension during exercise (author's transl)].
    Donzeau JP; Birmacker A; Bernadet P; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1978 Oct; 27(5):407-9. PubMed ID: 32825
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of metabolites in the relationship between pharmacokinetics and the effect of beta blockers. Studies on tolamolol and bufuralol].
    Tschopp JM; Gorgia A; Balant L; Revillard C; Francis RJ; Fabre FJ
    Schweiz Med Wochenschr; 1978 May; 108(20):756-64. PubMed ID: 26114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic-pharmacodynamic analyses of antihypertensive drugs, nifedipine and propranolol, in spontaneously hypertensive rats to investigate characteristics of effect and side effects.
    Kiriyama A; Honbo A; Nishimura A; Shibata N; Iga K
    Regul Toxicol Pharmacol; 2016 Apr; 76():21-9. PubMed ID: 26773344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug.
    Balnave K; Neill JD; Russell CJ; Harron DW; Leahey WJ; Wilson R; Shanks RG
    Br J Clin Pharmacol; 1981 Feb; 11(2):171-80. PubMed ID: 6111331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum thromboxane B2 after intravenous administration of talinolol and propranolol in healthy subjects.
    Sziegoleit W; Block HU; Fahr A; Mest HJ
    Pharmazie; 1991 Jan; 46(1):58-9. PubMed ID: 1677468
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of policosanol on arterial blood pressure in rats. Study of the pharmacological interaction with nifedipine and propranolol.
    Molina Cuevas V; Arruzazabala ML; Carbajal Quintana D; Más Ferreiro R; Valdés García S
    Arch Med Res; 1998; 29(1):21-4. PubMed ID: 9556918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of the beta 1 selective beta blocker, betaxolol, on metabolism in type II diabetics].
    Janka HU; Ziegler AG; Larrat V; Mehnert H
    Arzneimittelforschung; 1989 May; 39(5):615-7. PubMed ID: 2569309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
    Pandhi P; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings: Preliminary observations on the human pharmacology of I.C.I. 66082 in normal volunteers.
    Graham BR; Littlejohns DW; Prichard BN; Scales B; Southorn P
    Br J Pharmacol; 1973 Sep; 49(1):154P-155P. PubMed ID: 4150762
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
    Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol.
    Clements JD; Jamali F
    Vascul Pharmacol; 2007 Jan; 46(1):52-9. PubMed ID: 16949884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of non-selective and selective beta-1-blockade on the plasma potassium response to hypoglycaemia.
    Saunders J; Prestwich SA; Avery AJ; Kilborn JR; Morselli PL; Sönksen PH
    Diabete Metab; 1981 Dec; 7(4):239-42. PubMed ID: 6120859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative haemodynamic effects of betaxolol and propranolol in patients with cirrhosis.
    Braillon A; Lee SS; Valla D; Geoffroy P; Sauvanet JP; Lebrec D
    Scand J Gastroenterol; 1988 Aug; 23(6):691-5. PubMed ID: 2902683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.